Detalhe da pesquisa
1.
mTORC2 deficiency in cutaneous dendritic cells potentiates CD8+ effector T cell responses and accelerates skin graft rejection.
Am J Transplant
; 19(3): 646-661, 2019 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-30129283
2.
Rictor deficiency in dendritic cells exacerbates acute kidney injury.
Kidney Int
; 94(5): 951-963, 2018 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-30190173
3.
mTORC2 Deficiency in Myeloid Dendritic Cells Enhances Their Allogeneic Th1 and Th17 Stimulatory Ability after TLR4 Ligation In Vitro and In Vivo.
J Immunol
; 194(10): 4767-76, 2015 May 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-25840913
4.
mTORC2 Deficiency Alters the Metabolic Profile of Conventional Dendritic Cells.
Front Immunol
; 10: 1451, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31338091
5.
Intratumoral delivery of mTORC2-deficient dendritic cells inhibits B16 melanoma growth by promoting CD8(+) effector T cell responses.
Oncoimmunology
; 5(6): e1146841, 2016 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-27471613